Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
J Gastroenterol. 2021 Feb;56(2):158-167. doi: 10.1007/s00535-020-01748-x. Epub 2020 Nov 20.
We recently reported the real-world changes in the etiologies of liver cirrhosis (LC) based on nationwide survey data and assessed the etiologies of LC with hepatocellular carcinoma (HCC).
Fifty-five participants from 68 institutions provided data on 23,637 patients with HCC-complicated LC. The changing trends in etiologies were assessed. We further analyzed the data from 29 hospitals that provided the annual number of newly identified HCC-complicated LC patients from 2008 to 2016 (N = 9362) without any missing years and assessed the transition in the real number of newly identified HCC-complicated LC cases.
In the overall cohort, hepatitis C virus (HCV) infection (60.3%) and hepatitis B virus (HBV) infection (12.9%) were the leading and third-most common causes of HCC-complicated LC in Japan, respectively. HCV infection was found to be the leading cause throughout Japan. The rate of viral hepatitis-related HCC decreased from 85.3 to 64.4%. Among non-viral etiologies, notable increases were observed in nonalcoholic steatohepatitis (NASH)-related HCC (from 1.5 to 7.2%) and alcoholic liver disease (ALD)-related HCC (from 8.5 to 18.6%). Regarding the real number of newly diagnosed patients, the number of patients with viral hepatitis-related HCC decreased, while the number of patients with non-viral HCC, particularly NASH-related HCC, increased.
Viral hepatitis has remained the main cause of HCC in Japan. However, the decrease in viral hepatitis-related HCC, particularly HCV-related HCC highly contributed to the etiological changes. In addition, the increased incidence of non-viral HCC, particularly NASH-related HCC, was involved in the changing etiologies of HCC-complicated LC in Japan.
我们最近根据全国性调查数据报告了肝硬化(LC)病因的真实变化,并评估了伴有肝细胞癌(HCC)的 LC 的病因。
来自 68 个机构的 55 名参与者提供了 23637 例 HCC 合并 LC 患者的数据。评估了病因的变化趋势。我们进一步分析了来自 29 家医院的数据,这些医院提供了 2008 年至 2016 年期间每年新确诊的 HCC 合并 LC 患者的数量(N=9362),且无任何缺失年份,并评估了新确诊的 HCC 合并 LC 病例的实际数量的转变。
在整个队列中,丙型肝炎病毒(HCV)感染(60.3%)和乙型肝炎病毒(HBV)感染(12.9%)是日本 HCC 合并 LC 的主要和第三常见病因。HCV 感染在日本各地均为主要病因。病毒性肝炎相关 HCC 的比例从 85.3%降至 64.4%。在非病毒性病因中,非酒精性脂肪性肝炎(NASH)相关 HCC(从 1.5%升至 7.2%)和酒精性肝病(ALD)相关 HCC(从 8.5%升至 18.6%)显著增加。关于新确诊患者的实际数量,病毒性肝炎相关 HCC 患者数量减少,而非病毒性 HCC 患者数量增加,特别是 NASH 相关 HCC 患者数量增加。
病毒性肝炎仍是日本 HCC 的主要病因。然而,病毒性肝炎相关 HCC,特别是 HCV 相关 HCC 的减少是病因变化的主要原因。此外,非病毒性 HCC,特别是 NASH 相关 HCC 的发病率增加也与日本 HCC 合并 LC 的病因变化有关。